Literature DB >> 21733927

Pharmacogenetics and pharmacogenomics: a clinical reality.

Roberta Ferraldeschi1, William G Newman.   

Abstract

Pharmacogenetics and pharmacogenomics strive to explain the interindividual variability in response to drugs due to genetic variation. For certain drugs, genetic tests can reduce adverse drug reactions and improve treatment efficacy. In this review, we will briefly consider some successful tests introduced into clinical practice and potential future developments.

Mesh：

Year:  2011        PMID： 21733927     DOI： 10.1258/acb.2011.011084

Source DB:  PubMed          Journal:  Ann Clin Biochem        ISSN： 0004-5632            Impact factor:   2.057


  4 in total

1.  Suggested components of the curriculum for nurses and midwives to enable them to develop essential knowledge and skills in genetics.

Authors:  Heather Skirton; Sivia Barnoy; Yurdagul Erdem; Charlotta Ingvoldstad; Rebecka Pestoff; Fulya Teksen; Jessica Williams
Journal:  J Community Genet       Date:  2012-05-09

2.  On the readiness of physicians for pharmacogenomics testing: an empirical assessment.

Authors:  N Amara; J Blouin-Bougie; D Bouthillier; J Simard
Journal:  Pharmacogenomics J       Date:  2017-06-13       Impact factor: 3.550

Review 3.  Influence of pharmacogenomic profiling prior to pharmaceutical treatment in metastatic colorectal cancer on cost effectiveness : a systematic review.

Authors:  Martin Frank; Thomas Mittendorf
Journal:  Pharmacoeconomics       Date:  2013-03       Impact factor: 4.981

Review 4.  Explaining additional genetic variation in complex traits.

Authors:  Matthew R Robinson; Naomi R Wray; Peter M Visscher
Journal:  Trends Genet       Date:  2014-03-11       Impact factor: 11.639
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.